Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 9526 - 9550 of 9764 in total
GW-3965 is a liver X receptor ligand.
Experimental
Lefradafiban is an oral platelet glycoprotein IIb/IIIa receptor antagonist being investigated in the treatment of angina.
Investigational
Azimilide is an investigational class III anti-arrhythmic drug that blocks fast and slow components of the delayed rectifier cardiac potassium channels. It is not approved for use in any country, but is currently in clinical trials in the United States.
Investigational
Matched Categories: … Membrane Transport Modulators …
Investigational
Experimental
PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments Associated With Schizophrenia.
Investigational
Matched Categories: … Glycine Plasma Membrane Transport Proteins, antagonists & inhibitors …
S-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer, and Stage IIIA Non Small Cell Lung Cancer, among others.
Investigational
Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.
Investigational
Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain.
Investigational
Taladegib has been used in trials studying the treatment of Solid Tumor, COLON CANCER, BREAST CANCER, Advanced Cancer, and Rhabdomyosarcoma, among others.
Investigational
Abexinostat has been used in trials studying the treatment of Sarcoma, Lymphoma, Leukemia, Lymphocytic, and Hodgkin Disease, among others. It is a novel, broad-spectrum hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity.
Investigational
L-NAME has been investigated for the treatment of Hypotension and Spinal Cord Injury.
Investigational
Cortivazol is under investigation in clinical trial NCT00804895 (Cluster Headache Cortivazol Injection (CHCI)).
Investigational
MK-8245 has been used in trials studying the treatment of Type 2 Diabetes Mellitus.
Investigational
GPX-150 has been used in trials studying the treatment of Soft Tissue Sarcoma and Advanced Solid Tumors - Phase 1 Population.
Investigational
Experimental
Experimental
Experimental
Displaying drugs 9526 - 9550 of 9764 in total